Amarin Corporation plc (AMRN)
NASDAQ·Healthcare·Biotechnology
$13.90
-0.21%
Mkt Cap $301.56M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 25, 2026 | $50.62M | $49.22M | -2.77% | $0.07 | $0.01 | -85.71% | — | — |
| Q4 2025 Oct 29, 2025 | $50.62M | $48.56M | -4.07% | $0.08 | $0.01 | -87.50% | — | — |
| Q3 2025 Jul 30, 2025 | $42.04M | $46.62M | +10.89% | -$0.66 | -$0.03 | +95.45% | — | — |
| Q2 2025 May 7, 2025 | $45.26M | $42.02M | -7.16% | -$1.12 | -$0.04 | +96.43% | — | — |
| Q1 2025 Mar 12, 2025 | $50.75M | $62.31M | +22.78% | -$1.20 | -$2.40 | -100.00% | — | — |
| Q4 2024 Oct 30, 2024 | $31.69M | $42.30M | +33.46% | -$1.00 | -$1.00 | +0.00% | — | — |
| Q3 2024 Jul 31, 2024 | $40.61M | $67.57M | +66.38% | $0.10 | $0.20 | +100.00% | — | — |
| Q2 2024 May 1, 2024 | $51.02M | $56.49M | +10.71% | -$0.80 | -$0.20 | +75.00% | — | — |
| Q1 2024 Feb 29, 2024 | $63.81M | $75.36M | +18.11% | -$0.01 | -$0.01 | -66.67% | — | — |
| Q4 2023 Nov 1, 2023 | $58.65M | $66.06M | +12.63% | -$0.04 | -$0.05 | -11.11% | — | — |
| Q3 2023 Aug 2, 2023 | $74.52M | $80.17M | +7.58% | -$0.40 | $0.40 | +200.00% | — | — |
| Q2 2023 May 3, 2023 | $80.36M | $85.97M | +6.99% | -$0.20 | $0.40 | +300.00% | — | — |
| Q1 2023 Mar 1, 2023 | $82.19M | $90.25M | +9.80% | $0.20 | $0.40 | +100.00% | — | — |
| Q4 2022 Oct 27, 2022 | $88.17M | $89.88M | +1.94% | -$0.40 | $0.40 | +200.00% | — | — |
| Q3 2022 Aug 3, 2022 | $88.26M | $94.44M | +7.00% | -$1.40 | -$3.60 | -157.14% | — | — |
| Q2 2022 May 4, 2022 | $128.30M | $94.63M | -26.24% | -$0.40 | -$1.20 | -200.00% | — | — |
| Q1 2022 Mar 1, 2022 | $141.33M | $144.49M | +2.23% | $0.60 | $1.20 | +100.00% | — | — |
| Q4 2021 Nov 3, 2021 | $162.75M | $142.04M | -12.73% | -$0.20 | $0.60 | +400.00% | — | — |
| Q3 2021 Aug 5, 2021 | $152.69M | $154.49M | +1.18% | -$1.00 | $0.60 | +160.00% | — | — |
| Q2 2021 Apr 29, 2021 | $245.36M | $142.17M | -42.06% | -$0.05 | $0.60 | +1300.00% | — | — |